Chatham Therapeutics LLC is categorized under Biological Products Manufacturers in Chapel Hill, NC and active since 2010.
Chatham Therapeutics LLC was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 325414 by the NAICS.
If you are seeking more information, feel free to contact Richard Jude Samulski at the company’s single location by writing to 45 North Chatham Parkway, Chapel Hill, North Carolina NC 27517 or by phoning (919) 968-2727. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Chatham Therapeutics LLC |
| Contact Person: | Richard Jude Samulski |
| Address: | 45 North Chatham Parkway, Chapel Hill, North Carolina 27517 |
| Phone Number: | (919) 968-2727 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Products Manufacturers |
| SIC Code: | 2836 |
| NAICS Code: | 325414 |
| Share This Business: |
Chatham Therapeutics LLC was started in 2010 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Richard Jude Samulski for inquiries that concern Chatham Therapeutics LLC by calling the company number (919) 968-2727, as your correspondence is most welcome. Additionally, the physical location of the single location of Chatham Therapeutics LLC can be found at the coordinates as well as the street address 45 North Chatham Parkway in Chapel Hill, North Carolina 27517.
For its online presence, you may visit Chatham Therapeutics LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.